These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 25740845)
1. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Mattis VB; Tom C; Akimov S; Saeedian J; Østergaard ME; Southwell AL; Doty CN; Ornelas L; Sahabian A; Lenaeus L; Mandefro B; Sareen D; Arjomand J; Hayden MR; Ross CA; Svendsen CN Hum Mol Genet; 2015 Jun; 24(11):3257-71. PubMed ID: 25740845 [TBL] [Abstract][Full Text] [Related]
2. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H Mol Brain; 2012 May; 5():17. PubMed ID: 22613578 [TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. HD iPSC Consortium Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968 [TBL] [Abstract][Full Text] [Related]
4. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
5. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells. Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411 [TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington's Disease. Mathkar PP; Suresh D; Dunn J; Tom CM; Mattis VB J Huntingtons Dis; 2019; 8(3):257-269. PubMed ID: 31381521 [TBL] [Abstract][Full Text] [Related]
9. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics. Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279 [TBL] [Abstract][Full Text] [Related]
10. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease. Ma Q; Yang J; Li T; Milner TA; Hempstead BL Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324 [TBL] [Abstract][Full Text] [Related]
11. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells. Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease. Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770 [TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146 [TBL] [Abstract][Full Text] [Related]
14. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015 [TBL] [Abstract][Full Text] [Related]